Susquehanna International Group, LLP Relmada Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$2.3 - $4.36 $223,099 - $422,920	97,000 Added 320.13%	127,300 $412,000
Q2 2024 Aug 15, 2024	BUY	$2.93 - $4.94 $19,045 - $32,110	6,500 Added 27.31%	30,300 $90,000
Q1 2024 May 07, 2024	BUY	$3.1 - $6.8 $73,780 - $161,840	23,800 New	23,800 $110,000
Q4 2022 Feb 14, 2023	SELL	$2.17 - $35.84 $155,155 - $2.56 Million	-71,500 Reduced 32.96%	145,400 $507,000
Q3 2022 Nov 14, 2022	BUY	$18.3 - $37.02 $1.35 Million - $2.74 Million	73,900 Added 51.68%	216,900 $8.03 Million
Q2 2022 Aug 15, 2022	BUY	$16.5 - $30.34 $384,450 - $706,922	23,300 Added 19.47%	143,000 $2.72 Million
Q1 2022 May 16, 2022	BUY	$16.72 - $26.99 $825,968 - $1.33 Million	49,400 Added 70.27%	119,700 $3.23 Million
Q4 2021 Feb 14, 2022	BUY	$16.93 - $26.82 $164,221 - $260,154	9,700 Added 16.01%	70,300 $1.58 Million
Q3 2021 Nov 15, 2021	BUY	$21.86 - $34.77 $76,510 - $121,695	3,500 Added 6.13%	60,600 $1.59 Million
Q2 2021 Aug 11, 2021	SELL	$29.55 - $39.15 $673,740 - $892,620	-22,800 Reduced 28.54%	57,100 $1.83 Million
Q1 2021 May 17, 2021	BUY	$31.52 - $39.28 $1.15 Million - $1.43 Million	36,400 Added 83.68%	79,900 $2.81 Million
Q4 2020 Feb 16, 2021	SELL	$29.88 - $39.8 $660,348 - $879,579	-22,100 Reduced 33.69%	43,500 $1.4 Million
Q3 2020 Nov 16, 2020	SELL	$34.42 - $43.78 $234,056 - $297,704	-6,800 Reduced 9.39%	65,600 $2.47 Million
Q2 2020 Aug 14, 2020	BUY	$31.59 - $49.98 $1.5 Million - $2.37 Million	47,400 Added 189.6%	72,400 $3.24 Million
Q1 2020 May 15, 2020	SELL	$23.78 - $50.12 $66,584 - $140,336	-2,800 Reduced 10.07%	25,000 $853,000
Q4 2019 Feb 14, 2020	BUY	$10.1 - $47.18 $280,780 - $1.31 Million	27,800 New	27,800 $1.08 Million

Others Institutions Holding RLMD

# of Institutions

Shares Held

12.3M

Call Options Held

229K

Put Options Held

138K

Franklin Resources Inc San Mateo, CA

1.3M
Shares

$3.92 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.26M
Shares

$3.78 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

1.19M
Shares

$3.57 Million
0.01% of portfolio
Parsons Capital Management Inc

1M
Shares

$3.02 Million
0.21% of portfolio
Palo Alto Investors LP Palo Alto, CA

732K
Shares

$2.2 Million
0.33% of portfolio

View Full List

About RELMADA THERAPEUTICS, INC.

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $86.1M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

More about RLMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account